ArticleClinical and molecular hepatology2025
Reply to correspondence on "Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting".
Antonio Bertoletti et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.